ResearcherFred Hutch Cancer CenterActive in the last 2 years
Cassian Yee
Matched on ORCID iD 0000-0002-4429-7307; OpenAlex author ID A5028161783; NIH RePORTER profile ID 1871649. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 1)
- Trials
- 0
- Grants
- 1
- Labs led
- 1
- Collaborators
- 53
2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: 2 papers · 2019: 2 papers · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 grant · 2024: none · 2025: 1 paper
Papers 7
- Spatial mapping of transcriptomic plasticity in metastatic pancreatic cancer. Co-author DOI 10.1038/s41586-025-08927-x↗
- Combination of PD-1 Inhibitor and OX40 Agonist Induces Tumor Rejection and Immune Memory in Mouse Models of Pancreatic Cancer. Last author DOI 10.1053/j.gastro.2020.03.018↗
- Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer. Co-author DOI 10.1073/pnas.1811067116↗
- Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients. Co-author DOI 10.3389/fimmu.2019.00496↗
- Generation and testing of clinical-grade exosomes for pancreatic cancer. Co-author DOI 10.1172/jci.insight.99263↗
- Dynamic changes during the treatment of pancreatic cancer. Co-author DOI 10.18632/oncotarget.24483↗
- Pancreatic ductal adenocarcinoma contains an effector and regulatory immune cell infiltrate that is altered by multimodal neoadjuvant treatment. Co-author DOI 10.1371/journal.pone.0096565↗
Grants 1
Closest collaborators
The 25 strongest of 53 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Anirban Maitra · 5 shared papers, 2018–2025 · strength 0.47
- Paper Spatial mapping of transcriptomic plasticity in metastatic pancreatic cancer. DOI 10.1038/s41586-025-08927-x↗
- Paper Combination of PD-1 Inhibitor and OX40 Agonist Induces Tumor Rejection and Immune Memory in Mouse Models of Pancreatic … DOI 10.1053/j.gastro.2020.03.018↗
- Paper Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic… DOI 10.1073/pnas.1811067116↗
- Vincent Bernard · 2 shared papers, 2018–2025 · strength 0.23
- Hervé Tiriac · 2 shared papers, 2018–2025 · strength 0.23
- Huamin Wang · 2 shared papers, 2019–2020 · strength 0.18
- Paper Combination of PD-1 Inhibitor and OX40 Agonist Induces Tumor Rejection and Immune Memory in Mouse Models of Pancreatic … DOI 10.1053/j.gastro.2020.03.018↗
- Paper Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic… DOI 10.1073/pnas.1811067116↗
- Alexander Semaan · 1 shared paper, 2025 · strength 0.17
- Thomas C. Caffrey · 1 shared paper, 2025 · strength 0.17
- Benson Chellakkan Selvanesan · 1 shared paper, 2025 · strength 0.17
- Jean L. Grem · 1 shared paper, 2025 · strength 0.17
- Fredrik I. Thege · 1 shared paper, 2025 · strength 0.17
- Jimin Min · 1 shared paper, 2025 · strength 0.17
- Bharti Garg · 1 shared paper, 2025 · strength 0.17
- Paola A. Guerrero · 1 shared paper, 2025 · strength 0.17
- Guangsheng Pei · 1 shared paper, 2025 · strength 0.17
- Andrew J. Aguirre · 1 shared paper, 2025 · strength 0.17
- Michael Anthony Hollingsworth · 1 shared paper, 2025 · strength 0.17
- Paul M. Grandgenett · 1 shared paper, 2025 · strength 0.17
- Andrew M. Lowy · 1 shared paper, 2025 · strength 0.17
- Matthew H. G. Katz · 2 shared papers, 2018–2019 · strength 0.12
- Gauri Rajani Varadhachary · 2 shared papers, 2018–2019 · strength 0.12
- Jianhua Zhang · 1 shared paper, 2020 · strength 0.11
- Ying Ma · 1 shared paper, 2020 · strength 0.11
- Seon Ah Lim · 1 shared paper, 2019 · strength 0.08
- Kyung‐Mi Lee · 1 shared paper, 2019 · strength 0.08
- Seong‐Jin Kim · 1 shared paper, 2019 · strength 0.08
- Jin‐Young Jang · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.